Ortoma Future Growth
Future criteria checks 5/6
Ortoma is forecast to grow earnings and revenue by 59% and 36.2% per annum respectively. EPS is expected to grow by 5.9% per annum. Return on equity is forecast to be -4% in 3 years.
Key information
59.0%
Earnings growth rate
5.9%
EPS growth rate
Medical Equipment earnings growth | 23.5% |
Revenue growth rate | 36.2% |
Future return on equity | -4.0% |
Analyst coverage | Low |
Last updated | 21 Feb 2024 |
Recent future growth updates
Recent updates
Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business
Oct 25Ortoma (STO:ORT B) Is Doing The Right Things To Multiply Its Share Price
Sep 20We're Keeping An Eye On Ortoma's (STO:ORT B) Cash Burn Rate
Jun 03We Think Ortoma (NGM:ORT B) Can Afford To Drive Business Growth
Dec 09Ortoma (NGM:ORT B) Is In A Good Position To Deliver On Growth Plans
Aug 17Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 124 | -7 | -9 | -1 | 1 |
12/31/2025 | 59 | -31 | -26 | -17 | 1 |
12/31/2024 | 88 | 18 | 1 | 13 | 1 |
12/31/2023 | 62 | -22 | -11 | 13 | N/A |
9/30/2023 | 48 | 1 | -21 | 4 | N/A |
6/30/2023 | 44 | 0 | -22 | 6 | N/A |
3/31/2023 | 33 | -8 | -27 | -2 | N/A |
12/31/2022 | 23 | -16 | -32 | -8 | N/A |
9/30/2022 | 21 | -11 | -34 | -13 | N/A |
6/30/2022 | 19 | -12 | -34 | -14 | N/A |
3/31/2022 | 20 | -11 | -35 | -15 | N/A |
12/31/2021 | 20 | -11 | -35 | -15 | N/A |
9/30/2021 | 20 | -12 | -31 | -11 | N/A |
6/30/2021 | 20 | -11 | -30 | -10 | N/A |
3/31/2021 | 20 | -9 | -28 | -8 | N/A |
12/31/2020 | 18 | -9 | -27 | -8 | N/A |
9/30/2020 | 17 | -9 | -27 | -10 | N/A |
6/30/2020 | 16 | -9 | -27 | -11 | N/A |
3/31/2020 | 14 | -10 | -24 | -11 | N/A |
12/31/2019 | 12 | -10 | -21 | -9 | N/A |
9/30/2019 | 11 | -8 | -18 | -6 | N/A |
6/30/2019 | 11 | -7 | -15 | -5 | N/A |
3/31/2019 | 11 | -7 | -18 | -7 | N/A |
12/31/2018 | 12 | -8 | -21 | -9 | N/A |
9/30/2018 | 14 | -8 | -26 | -13 | N/A |
6/30/2018 | 16 | -8 | -34 | -18 | N/A |
3/31/2018 | 16 | -8 | -24 | -8 | N/A |
12/31/2017 | 17 | -7 | -22 | -6 | N/A |
9/30/2017 | 17 | -7 | N/A | -3 | N/A |
6/30/2017 | 16 | -6 | N/A | 4 | N/A |
3/31/2017 | 16 | -5 | N/A | -3 | N/A |
12/31/2016 | 15 | -5 | N/A | -4 | N/A |
9/30/2016 | 13 | -4 | N/A | -2 | N/A |
6/30/2016 | 11 | -4 | N/A | -3 | N/A |
3/31/2016 | 10 | -4 | N/A | -2 | N/A |
12/31/2015 | 9 | -4 | N/A | -4 | N/A |
9/30/2015 | 9 | -4 | N/A | -4 | N/A |
6/30/2015 | 9 | -5 | N/A | -5 | N/A |
3/31/2015 | 9 | -5 | N/A | -6 | N/A |
12/31/2014 | 8 | -4 | N/A | -5 | N/A |
9/30/2014 | 6 | -4 | N/A | -5 | N/A |
6/30/2014 | 4 | -4 | N/A | -4 | N/A |
3/31/2014 | 3 | -3 | N/A | -3 | N/A |
12/31/2013 | 3 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ORT B is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: ORT B is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ORT B is expected to become profitable in the next 3 years.
Revenue vs Market: ORT B's revenue (36.2% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: ORT B's revenue (36.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ORT B is forecast to be unprofitable in 3 years.